Voriconazole Injection, Powder, Lyophilized, For Solution
Product Images NDC 70594-067

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 70594-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Voriconazole 01)

Chemical structure diagram of voriconazole, showing its molecular framework with ring systems, fluorine atoms, and functional groups consistent with this antifungal agent.*

FDA Label Image

Principal Display Panel (200 MG Vial Label)

Label for Voriconazole for Injection 200 mg per vial, lyophilized powder for injection by Xellia Pharmaceuticals USA LLC. The label includes dilution instructions to reconstitute with 19 mL water and further dilute for intravenous use. It states the vial contains 200 mg voriconazole and 3200 mg hydroxypropyl ß-cyclodextrin. The label notes no natural rubber latex or preservatives and specifies single-dose vial usage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.